A Non-Interventional Long-Term Post-Marketing Registry of Patients Treated with Certolizumab Pegol (Cimzia) for Crohn's Disease - C87075

Grants and Contracts Details

StatusFinished
Effective start/end date2/9/109/28/21

Funding

  • Schwarz BioSciences Inc: $96,009.00